Clinical Trials Browser

Completed × sacituzumab govitecan × Other solid neoplasm × Clear all

NCT04319198 2025-09-30

Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy

Phase 4 Completed

25 enrolled 15 charts

Other solid neoplasm

Metastatic Solid Tumors